During the past decade, Royal Melbourne Hospital; Department of Neurology conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Royal Melbourne Hospital; Department of Neurology" #1 collaborator was "Bayer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Royal Melbourne Hospital; Department of Neurology" are "Multiple Sclerosis, Relapsing-Remitting" (2 trials), "Huntingtons Disease" (1 trials) and "Multiple Sclerosis, Primary Progressive" (1 trials). Many other conditions were trialed in "Royal Melbourne Hospital; Department of Neurology" in a lesser frequency.

Most popular intervention types in "Royal Melbourne Hospital; Department of Neurology" are "Drug" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ocrelizumab" (2 trials), "Alemtuzumab 12 mg" (1 trials), "Alemtuzumab 24 mg" (1 trials), "Fenebrutinib" (1 trials) and "Interferon beta-1a" (1 trials). Other intervention names were less common.

The vast majority of trials in "Royal Melbourne Hospital; Department of Neurology" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Royal Melbourne Hospital; Department of Neurology". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Royal Melbourne Hospital; Department of Neurology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Royal Melbourne Hospital; Department of Neurology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".